Clinical Trial 39503

Winter Haven, FL 33880


Summary:

The primary objective of this study is to evaluate the safety and tolerability of litoxetine up to 30mg vs. placebo adiministered orally twice daily (BID) for 8 weeks in subjects with a diagnosis of urinary incontinence (UI)

The seconday objective of this study is to evaluate teh efficacy of litoxetine up to 30mg BID compared to placebo in subjects with a diagnosis of UI.


Qualified Participants Must:

• Be between 18-70 years of age
• (Males) Undergone prostatectomy at least 6 months prior to screening
• Have not had more than 4 urinary tract infections (UTI's) within a year prior to screening


Qualified Participants May Receive:

- Study related treatment

- Compensation for time and travel expenses

- Study related lab work (blood work, ECG, PVR, etc.)

- Oversight by a board certified physician


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.